,trastuzumab deruxtecan
roche,astrazeneca,daiichi sankyo
['destiny breast03', 'trastuzumab', 'breast']
an honor to introduce our faculty presenting destiny breast03 at #asco22 trastuzumab deruxtecan trastuzumab emtansine in her2 unresectable and/or metastatic #breastcancer safety follow up best 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??